患者报告的 adrenoleukodystrophy (PRISM-ALD) 症状的影响
Anika Varma1, Jennifer Weinstein2, Jamison Seabury2
1Center for Health + Technology, University of Rochester, 265 Crittenden Blvd, CU 420694, Rochester, NY, 14642, USA. anika.varma@chet.rochester.edu.
Orphanet journal of rare diseases
|March 20, 2024
概括
像平衡问题,运动限制,疲劳和腿部软弱等腺核性白血病 (ALD) 症状对患者产生重大影响. 识别这些普遍的症状对于开发针对性研究和治疗这种神经退行性疾病至关重要.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 罕见疾病 罕见疾病
背景情况:
- 上腺核衰竭 (ALD) 是一种复杂的X关联神经退行性疾病,具有多样化的临床表现.
- ALD显著影响患者的身体,情感和社会福祉,有助于整体疾病负担.
研究的目的:
- 为了识别患有腺核性白细胞缩症 (ALD) 个体所经历的最常见和最有影响力的症状.
- 通过了解患者报告的ALD亚型的症状负担,为临床护理和研究提供信息.
主要方法:
- 与17名ALD患者进行了半结构化的定性访谈.
- 对109名成人ALD参与者进行了一项国际横截面研究.
- 收集了24个主题中的182个独特症状的数据,按人口统计和临床特征分类.
主要成果:
- 最常见的症状包括平衡问题 (90.9%),运动/行走限制 (87.3%),疲劳 (86.4%) 和腿部软弱 (86.4%).
- 影响评分最高的是难以移动 (2.35),腿部软弱 (2.25) 和平衡问题 (2.21).
- 症状发生率增加与功能障碍,就业中断和语言障碍相关.
结论:
- 许多与患者相关的症状有助于增强腺核白细胞衰竭 (ALD) 的疾病负担.
- 这些确定的症状作为未来研究和ALD治疗干预的关键目标.
关键词:
adrenoleukodystrophy ( adrenoleukodystrophy) 的意思是腺核细胞衰竭,也就是说 adrenoleukodystrophy ( adrenoleukodystrophy) 的意思是腺核细胞衰竭.上腺核髓单元性神经病变横截面研究 横截面研究疾病负担 疾病负担患者采访 患者采访患者报告的患者报告定性研究是一种定性研究.症状 症状 症状 症状更多相关视频
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
10.4K
08:16Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
31.8K
相关概念视频
01:22Alzheimer's Disease: Treatment
186
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
186
01:26Alzheimer's Disease: Overview
475
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
475
01:17Drugs for Treatment of Diarrhea-Predominant IBS
167
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
167